<?xml version="1.0" encoding="UTF-8"?><COCHRANE_REVIEW DESCRIPTION="Support: for Publication" DOI="10.1002/14651858.CD015322.pub2" GROUP_ID="ENT" ID="497421100616324510" MERGED_FROM="" MODIFIED="2021-11-01 14:27:50 +0000" MODIFIED_BY="8773" REVIEW_NO="MIGRAIN3" REVMAN_SUB_VERSION="6.0.0" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="1.7"><COVER_SHEET MODIFIED="2021-10-06 16:32:41 +0000" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8"><TITLE>Pharmacological interventions for acute attacks of vestibular migraine</TITLE><CONTACT MODIFIED="2023-04-11 11:37:29 +0000" MODIFIED_BY="z2201291045289054028217907586210"><PERSON ID="5B1A013182E26AA200AF683A366CF7F3" MODIFIED="2023-04-11 11:37:29 +0000" MODIFIED_BY="z2201291045289054028217907586210" ROLE="AUTHOR"><FIRST_NAME>Katie</FIRST_NAME><MIDDLE_INITIALS>E</MIDDLE_INITIALS><LAST_NAME>Webster</LAST_NAME><EMAIL_1>katie.webster@doctors.org.uk</EMAIL_1><ADDRESS><DEPARTMENT>Cochrane ENT</DEPARTMENT><ORGANISATION>Nuffield Department of Surgical Sciences, University of Oxford</ORGANISATION><CITY>Oxford</CITY><COUNTRY CODE="GB">UK</COUNTRY></ADDRESS></PERSON></CONTACT><CREATORS MODIFIED="2023-04-11 11:37:29 +0000" MODIFIED_BY="z2201291045289054028217907586210"><PERSON ID="5B1A013182E26AA200AF683A366CF7F3" MODIFIED="2023-04-11 11:37:29 +0000" MODIFIED_BY="z2201291045289054028217907586210" ROLE="AUTHOR"><FIRST_NAME>Katie</FIRST_NAME><MIDDLE_INITIALS>E</MIDDLE_INITIALS><LAST_NAME>Webster</LAST_NAME><EMAIL_1>katie.webster@doctors.org.uk</EMAIL_1><ADDRESS><DEPARTMENT>Cochrane ENT, Nuffield Department of Surgical Sciences</DEPARTMENT><ORGANISATION>University of Oxford</ORGANISATION><CITY>Oxford</CITY><COUNTRY CODE="GB">UK</COUNTRY></ADDRESS></PERSON><PERSON ID="z2103151100477519552273879962645" MODIFIED="2023-04-11 11:37:29 +0000" MODIFIED_BY="z2201291045289054028217907586210" ROLE="AUTHOR"><FIRST_NAME>Afrose</FIRST_NAME><LAST_NAME>Dor</LAST_NAME><EMAIL_1>afrose.dor@wadham.ox.ac.uk</EMAIL_1><ADDRESS><DEPARTMENT>Wadham College</DEPARTMENT><ORGANISATION>University of Oxford</ORGANISATION><CITY>Oxford</CITY><COUNTRY CODE="GB">UK</COUNTRY></ADDRESS><FOOTNOTE>These authors contributed equally</FOOTNOTE></PERSON><PERSON ID="z2001201455262583895685719757999" MODIFIED="2023-04-11 11:37:29 +0000" MODIFIED_BY="z2201291045289054028217907586210" ROLE="AUTHOR"><FIRST_NAME>Kevin</FIRST_NAME><LAST_NAME>Galbraith</LAST_NAME><EMAIL_1>kevin.galbraith@nds.ox.ac.uk</EMAIL_1><ADDRESS><DEPARTMENT>Cochrane ENT</DEPARTMENT><ORGANISATION>Nuffield Department of Surgical Sciences, University of Oxford</ORGANISATION><CITY>Oxford</CITY><COUNTRY CODE="GB">UK</COUNTRY></ADDRESS></PERSON><PERSON ID="z1712261610390429352282217246189" MODIFIED="2023-04-11 11:37:29 +0000" MODIFIED_BY="z2201291045289054028217907586210" ROLE="AUTHOR"><FIRST_NAME>Luma</FIRST_NAME><LAST_NAME>Haj Kassem</LAST_NAME><EMAIL_1>lumahk055@outlook.com</EMAIL_1><ADDRESS><ORGANISATION>Aleppo University Hospital</ORGANISATION><CITY>Aleppo</CITY><COUNTRY CODE="SY">Syrian Arab Republic</COUNTRY></ADDRESS><FOOTNOTE>These authors contributed equally</FOOTNOTE></PERSON><PERSON ID="z2108060943159876559960952123653" MODIFIED="2023-04-11 11:37:29 +0000" MODIFIED_BY="z2201291045289054028217907586210" ROLE="AUTHOR"><FIRST_NAME>Natasha</FIRST_NAME><MIDDLE_INITIALS>A</MIDDLE_INITIALS><LAST_NAME>Harrington-Benton</LAST_NAME><EMAIL_1>natasha@menieres.org.uk</EMAIL_1><ADDRESS><ORGANISATION>Ménière's Society</ORGANISATION><CITY>Dorking</CITY><COUNTRY CODE="GB">UK</COUNTRY></ADDRESS></PERSON><PERSON ID="z2108060949094257247343818859942" MODIFIED="2023-04-11 11:37:29 +0000" MODIFIED_BY="z2201291045289054028217907586210" ROLE="AUTHOR"><FIRST_NAME>Owen</FIRST_NAME><LAST_NAME>Judd</LAST_NAME><EMAIL_1>owenjudd@doctors.org.uk</EMAIL_1><ADDRESS><DEPARTMENT>ENT Department</DEPARTMENT><ORGANISATION>University Hospitals of Derby and Burton NHS Foundation Trust</ORGANISATION><CITY>Derby</CITY><COUNTRY CODE="GB">UK</COUNTRY></ADDRESS></PERSON><PERSON ID="z2108060956464106027345580608301" MODIFIED="2023-04-11 11:37:29 +0000" MODIFIED_BY="z2201291045289054028217907586210" ROLE="AUTHOR"><FIRST_NAME>Diego</FIRST_NAME><LAST_NAME>Kaski</LAST_NAME><EMAIL_1>d.kaski@ucl.ac.uk</EMAIL_1><ADDRESS><ORGANISATION>National Hospital for Neurology and Neurosurgery</ORGANISATION><CITY>London</CITY><COUNTRY CODE="GB">UK</COUNTRY></ADDRESS></PERSON><PERSON ID="z2108061001312325012751953194962" MODIFIED="2023-04-11 11:37:29 +0000" MODIFIED_BY="z2201291045289054028217907586210" ROLE="AUTHOR"><FIRST_NAME>Otto</FIRST_NAME><MIDDLE_INITIALS>R</MIDDLE_INITIALS><LAST_NAME>Maarsingh</LAST_NAME><EMAIL_1>o.maarsingh@amsterdamumc.nl</EMAIL_1><ADDRESS><DEPARTMENT>Amsterdam UMC, Vrije Universiteit Amsterdam, Department of General Practice</DEPARTMENT><ORGANISATION>Amsterdam Public Health Research Institute</ORGANISATION><CITY>Amsterdam</CITY><COUNTRY CODE="NL">Netherlands</COUNTRY></ADDRESS></PERSON><PERSON ID="z2005041451280480946175458053440" MODIFIED="2023-04-11 11:37:29 +0000" MODIFIED_BY="z2201291045289054028217907586210" ROLE="AUTHOR"><FIRST_NAME>Samuel</FIRST_NAME><LAST_NAME>MacKeith</LAST_NAME><EMAIL_1>samuel.mackeith@ouh.nhs.uk</EMAIL_1><ADDRESS><DEPARTMENT>ENT Department</DEPARTMENT><ORGANISATION>Oxford University Hospitals NHS Foundation Trust</ORGANISATION><CITY>Oxford</CITY><COUNTRY CODE="GB">UK</COUNTRY></ADDRESS></PERSON><PERSON ID="z2108061004302876403594766694595" MODIFIED="2023-04-11 11:37:29 +0000" MODIFIED_BY="z2201291045289054028217907586210" ROLE="AUTHOR"><FIRST_NAME>Jaydip</FIRST_NAME><LAST_NAME>Ray</LAST_NAME><EMAIL_1>jaydip.ray1@nhs.net</EMAIL_1><ADDRESS><ORGANISATION>University of Sheffield</ORGANISATION><CITY>Sheffield</CITY><COUNTRY CODE="GB">UK</COUNTRY></ADDRESS></PERSON><PERSON ID="z2108061007305939699013315739257" MODIFIED="2023-04-11 11:37:29 +0000" MODIFIED_BY="z2201291045289054028217907586210" ROLE="AUTHOR"><FIRST_NAME>Vincent</FIRST_NAME><MIDDLE_INITIALS>A</MIDDLE_INITIALS><LAST_NAME>Van Vugt</LAST_NAME><EMAIL_1>v.vanvugt@amsterdamumc.nl</EMAIL_1><ADDRESS><DEPARTMENT>Amsterdam UMC, Vrije Universiteit Amsterdam, Department of General Practice</DEPARTMENT><ORGANISATION>Amsterdam Public Health Research Institute</ORGANISATION><CITY>Amsterdam</CITY><COUNTRY CODE="NL">Netherlands</COUNTRY></ADDRESS></PERSON><PERSON ID="BE67C2AB82E26AA2014A5594476783BD" MODIFIED="2023-04-11 11:37:29 +0000" MODIFIED_BY="z2201291045289054028217907586210" ROLE="AUTHOR"><FIRST_NAME>Martin</FIRST_NAME><MIDDLE_INITIALS>J</MIDDLE_INITIALS><LAST_NAME>Burton</LAST_NAME><EMAIL_1>martin.burton@cochrane.nhs.uk</EMAIL_1><ADDRESS><DEPARTMENT>Nuffield Department of Surgical Sciences</DEPARTMENT><ORGANISATION>University of Oxford</ORGANISATION><CITY>Oxford</CITY><COUNTRY CODE="GB">UK</COUNTRY></ADDRESS></PERSON></CREATORS><DATES MODIFIED="2023-04-11 11:37:29 +0000" MODIFIED_BY="z2201291045289054028217907586210"><UP_TO_DATE><DATE DAY="" MONTH="" YEAR=""/></UP_TO_DATE><LAST_SEARCH><DATE DAY="23" MONTH="9" YEAR="2022"/></LAST_SEARCH><NEXT_STAGE><DATE DAY="" MONTH="" YEAR=""/></NEXT_STAGE><PROTOCOL_PUBLISHED ISSUE="3" YEAR="2022"/><REVIEW_PUBLISHED ISSUE="" YEAR=""/><LAST_CITATION_ISSUE ISSUE="3" YEAR="2022"/></DATES><WHATS_NEW/><HISTORY/><SOURCES_OF_SUPPORT MODIFIED="2021-10-06 16:32:41 +0000" MODIFIED_BY="6CC7734682E26AA2008F53C85074DEB8"><INTERNAL_SOURCES/><EXTERNAL_SOURCES/></SOURCES_OF_SUPPORT><MESH_TERMS VERIFIED="NO"/><KEYWORDS/></COVER_SHEET><MAIN_TEXT><SUMMARY><TITLE/><SUMMARY_BODY/></SUMMARY><ABSTRACT><ABS_BACKGROUND/><ABS_OBJECTIVES/><ABS_SEARCH_STRATEGY/><ABS_SELECTION_CRITERIA/><ABS_DATA_COLLECTION/><ABS_RESULTS/><ABS_CONCLUSIONS/></ABSTRACT><BODY><BACKGROUND><CONDITION/><INTERVENTION/><THEORY/><IMPORTANCE/></BACKGROUND><OBJECTIVES/><METHODS><SELECTION_CRITERIA><CRIT_STUDIES/><CRIT_PARTICIPANTS/><CRIT_INTERVENTIONS/><CRIT_OUTCOMES><CRIT_OUTCOMES_PRIMARY/><CRIT_OUTCOMES_SECONDARY/></CRIT_OUTCOMES></SELECTION_CRITERIA><SEARCH_METHODS><ELECTRONIC_SEARCHES/><OTHER_SEARCHES/></SEARCH_METHODS><DATA_COLLECTION><STUDY_SELECTION/><DATA_EXTRACTION/><QUALITY_ASSESSMENT/><EFFECT_MEASURES/><UNIT_OF_ANALYSIS/><MISSING_DATA/><HETEROGENEITY_ASSESSMENT/><BIAS_ASSESSMENT/><DATA_SYNTHESIS/><SUBGROUP_ANALYSIS/><SENSITIVITY_ANALYSIS/></DATA_COLLECTION></METHODS><RESULTS><STUDY_DESCRIPTION><SEARCH_RESULTS/><INCLUDED_STUDIES_DESCR/><EXCLUDED_STUDIES_DESCR/></STUDY_DESCRIPTION><STUDY_QUALITY><ALLOCATION/><BLINDING/><EXCLUSIONS/><SELECTIVE_REPORTING/><OTHER_BIAS_SOURCES/></STUDY_QUALITY><INTERVENTION_EFFECTS/></RESULTS><DISCUSSION><SUMMARY_OF_RESULTS/><APPLICABILITY_OF_FINDINGS/><QUALITY_OF_EVIDENCE/><POTENTIAL_BIASES/><AGREEMENT/></DISCUSSION><CONCLUSIONS><IMPLICATIONS_PRACTICE/><IMPLICATIONS_RESEARCH/></CONCLUSIONS></BODY><ACKNOWLEDGEMENTS/><CONFLICT_OF_INTEREST/><CONTRIBUTIONS/><PRO_REV_DIFF/><PUBLIC_NOTES/></MAIN_TEXT><STUDIES_AND_REFERENCES><STUDIES><INCLUDED_STUDIES><STUDY DATA_SOURCE="PUB" ID="STD-NCT02447991" NAME="NCT02447991" YEAR="2015"><IDENTIFIERS/></STUDY><STUDY DATA_SOURCE="PUB" ID="STD-Neuhauser-2003" NAME="Neuhauser 2003" YEAR="2003"><IDENTIFIERS/></STUDY></INCLUDED_STUDIES><EXCLUDED_STUDIES/><AWAITING_STUDIES/><ONGOING_STUDIES/></STUDIES><OTHER_REFERENCES><ADDITIONAL_REFERENCES/><OTHER_VERSIONS_REFERENCES/><PENDING_REFERENCES/></OTHER_REFERENCES></STUDIES_AND_REFERENCES><CHARACTERISTICS_OF_STUDIES><CHARACTERISTICS_OF_INCLUDED_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO"><INCLUDED_CHAR STUDY_ID="STD-NCT02447991"><CHAR_METHODS/><CHAR_PARTICIPANTS/><CHAR_INTERVENTIONS/><CHAR_OUTCOMES/><CHAR_NOTES/></INCLUDED_CHAR><INCLUDED_CHAR STUDY_ID="STD-Neuhauser-2003"><CHAR_METHODS/><CHAR_PARTICIPANTS/><CHAR_INTERVENTIONS/><CHAR_OUTCOMES/><CHAR_NOTES/></INCLUDED_CHAR><FOOTNOTES/></CHARACTERISTICS_OF_INCLUDED_STUDIES><CHARACTERISTICS_OF_EXCLUDED_STUDIES SORT_BY="STUDY"/><CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO"/><CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO"/></CHARACTERISTICS_OF_STUDIES><QUALITY_ITEMS MODIFIED="2022-12-12 11:35:40 +0000" MODIFIED_BY="8773"><QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2022-12-12 11:35:40 +0000" MODIFIED_BY="8773" NO="1"><NAME>Random sequence generation (selection bias)</NAME><DESCRIPTION><P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P></DESCRIPTION><QUALITY_ITEM_DATA><QUALITY_ITEM_DATA_ENTRY MODIFIED="2022-06-07 09:28:39 +0000" MODIFIED_BY="5B1A013182E26AA200AF683A366CF7F3" RESULT="UNKNOWN" STUDY_ID="STD-NCT02447991"><DESCRIPTION><P>Quote: "A randomization scheme will be developed to assign the 120 patients expected to be included in the Treatment Phase to parallel treatment arms in a 2:1 ratio of active drug:placebo." </P><P>Comment: no information is provided regarding generation of the randomisation sequence.</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2022-06-07 10:06:55 +0000" MODIFIED_BY="5B1A013182E26AA200AF683A366CF7F3" RESULT="UNKNOWN" STUDY_ID="STD-Neuhauser-2003"><DESCRIPTION><P>Comment: no information given on randomisation sequence generation.</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY></QUALITY_ITEM_DATA></QUALITY_ITEM><QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2022-12-12 11:35:40 +0000" MODIFIED_BY="8773" NO="2"><NAME>Allocation concealment (selection bias)</NAME><DESCRIPTION><P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P></DESCRIPTION><QUALITY_ITEM_DATA><QUALITY_ITEM_DATA_ENTRY MODIFIED="2022-06-07 09:29:01 +0000" MODIFIED_BY="5B1A013182E26AA200AF683A366CF7F3" RESULT="UNKNOWN" STUDY_ID="STD-NCT02447991"><DESCRIPTION><P>Comment: no information regarding how the randomisation process would occur and whether the randomisation list would be adequately concealed.</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2022-06-07 10:07:05 +0000" MODIFIED_BY="5B1A013182E26AA200AF683A366CF7F3" RESULT="UNKNOWN" STUDY_ID="STD-Neuhauser-2003"><DESCRIPTION><P>Comment: no information given on allocation concealment. </P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY></QUALITY_ITEM_DATA></QUALITY_ITEM><QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2022-12-12 11:35:40 +0000" MODIFIED_BY="8773" NO="3"><NAME>Blinding of participants and personnel (performance bias)</NAME><DESCRIPTION><P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P></DESCRIPTION><QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1"><NAME>All outcomes</NAME></QUALITY_ITEM_DATA_ENTRY_GROUP><QUALITY_ITEM_DATA><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2022-06-07 09:29:15 +0000" MODIFIED_BY="5B1A013182E26AA200AF683A366CF7F3" RESULT="YES" STUDY_ID="STD-NCT02447991"><DESCRIPTION><P>Comment: trial is reported to be blinded to participants and study personnel.</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2022-06-07 10:07:27 +0000" MODIFIED_BY="5B1A013182E26AA200AF683A366CF7F3" RESULT="UNKNOWN" STUDY_ID="STD-Neuhauser-2003"><DESCRIPTION><P>Comment: stated to be "double-blind" and placebo was used. No other information given on blinding of study personnel.</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY></QUALITY_ITEM_DATA></QUALITY_ITEM><QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2022-12-12 11:35:40 +0000" MODIFIED_BY="8773" NO="4"><NAME>Blinding of outcome assessment (detection bias)</NAME><DESCRIPTION><P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P></DESCRIPTION><QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1"><NAME>All outcomes</NAME></QUALITY_ITEM_DATA_ENTRY_GROUP><QUALITY_ITEM_DATA><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2022-06-07 09:29:29 +0000" MODIFIED_BY="5B1A013182E26AA200AF683A366CF7F3" RESULT="YES" STUDY_ID="STD-NCT02447991"><DESCRIPTION><P>Comment: self-reported symptoms by blinded participants.</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2022-06-07 10:07:39 +0000" MODIFIED_BY="5B1A013182E26AA200AF683A366CF7F3" RESULT="YES" STUDY_ID="STD-Neuhauser-2003"><DESCRIPTION><P>Quote: "placebo of identical appearance and taste" </P><P>Comment: primary outcome measures were self-reported symptoms by blinded participants.</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY></QUALITY_ITEM_DATA></QUALITY_ITEM><QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="GROUP" MODIFIED="2023-03-21 17:49:08 +0000" MODIFIED_BY="8773" NO="5"><NAME>Incomplete outcome data (attrition bias)</NAME><DESCRIPTION><P>Attrition bias due to amount, nature or handling of incomplete outcome data</P></DESCRIPTION><QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-05.01" NO="1"><NAME>All outcomes</NAME></QUALITY_ITEM_DATA_ENTRY_GROUP><QUALITY_ITEM_DATA><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-05.01" MODIFIED="2022-06-07 09:29:46 +0000" MODIFIED_BY="5B1A013182E26AA200AF683A366CF7F3" RESULT="NO" STUDY_ID="STD-NCT02447991"><DESCRIPTION><P>Comment: dropout was 22.2% in the placebo arm and 33.7% in the intervention arm, although some participants did provide partial follow-up data. This is sufficient to impact the results of the trial, and may introduce the potential for bias in the results.</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-05.01" MODIFIED="2022-06-07 10:08:02 +0000" MODIFIED_BY="5B1A013182E26AA200AF683A366CF7F3" RESULT="NO" STUDY_ID="STD-Neuhauser-2003"><DESCRIPTION><P>Comment: 3 withdrawals from the study (only 19 participants in total). In addition, 6 participants who did not suffer an attack during the study period (which is undefined) were also excluded from analysis, therefore further reduction in sample size.</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY></QUALITY_ITEM_DATA></QUALITY_ITEM><QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2023-03-21 17:49:08 +0000" MODIFIED_BY="8773" NO="6"><NAME>Selective reporting (reporting bias)</NAME><DESCRIPTION><P>Reporting bias due to selective outcome reporting</P></DESCRIPTION><QUALITY_ITEM_DATA><QUALITY_ITEM_DATA_ENTRY MODIFIED="2022-06-07 09:30:08 +0000" MODIFIED_BY="5B1A013182E26AA200AF683A366CF7F3" RESULT="YES" STUDY_ID="STD-NCT02447991"><DESCRIPTION><P>Comment: outcomes are fully reported on the trial registry website according to the pre-specified plan.</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2022-06-07 10:08:24 +0000" MODIFIED_BY="5B1A013182E26AA200AF683A366CF7F3" RESULT="NO" STUDY_ID="STD-Neuhauser-2003"><DESCRIPTION><P>Comment: data are not reported in a way that accounts for the cross-over design of this trial, therefore it is impossible to appropriately assess correlation in outcomes for an individual participant.</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY></QUALITY_ITEM_DATA></QUALITY_ITEM><QUALITY_ITEM CORE_ITEM="YES" ID="QIT-07" LEVEL="STUDY" MODIFIED="2022-12-12 11:35:40 +0000" MODIFIED_BY="8773" NO="7"><NAME>Other bias</NAME><DESCRIPTION><P>Bias due to problems not covered elsewhere in the table</P></DESCRIPTION><QUALITY_ITEM_DATA><QUALITY_ITEM_DATA_ENTRY MODIFIED="2022-06-07 09:30:20 +0000" MODIFIED_BY="5B1A013182E26AA200AF683A366CF7F3" RESULT="YES" STUDY_ID="STD-NCT02447991"><DESCRIPTION><P>Comment: no other concerns identified. </P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2022-11-25 12:32:42 +0000" MODIFIED_BY="5B1A013182E26AA200AF683A366CF7F3" RESULT="YES" STUDY_ID="STD-Neuhauser-2003"><DESCRIPTION><P>Comment: no other concerns identified. </P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY></QUALITY_ITEM_DATA></QUALITY_ITEM></QUALITY_ITEMS><SOF_TABLES/><ADDITIONAL_TABLES/><ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2022-06-24 09:28:32 +0000" MODIFIED_BY="z2001201455262583895685719757999"><COMPARISON ID="CMP-001" MODIFIED="2022-06-24 09:28:32 +0000" MODIFIED_BY="z2001201455262583895685719757999" NO="1"><NAME>Triptans versus placebo</NAME><DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" METHOD="MH" MODIFIED="2022-11-25 11:39:15 +0000" MODIFIED_BY="5B1A013182E26AA200AF683A366CF7F3" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0"><NAME>Improvement in vertigo (global score)</NAME><GROUP_LABEL_1>Triptans</GROUP_LABEL_1><GROUP_LABEL_2>Placebo</GROUP_LABEL_2><GRAPH_LABEL_1>Favours placebo</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours triptans</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="0.8348830109596344" CI_END="1.069791135902662" CI_START="0.6641907878673089" DF="1" EFFECT_SIZE="0.8429385608741912" ESTIMABLE="YES" EVENTS_1="76" EVENTS_2="55" I2="0.0" ID="CMP-001.01.01" LOG_CI_END="0.029298995087779698" LOG_CI_START="-0.17770715223377778" LOG_EFFECT_SIZE="-0.074204078572999" MODIFIED="2022-09-26 12:20:41 +0000" MODIFIED_BY="89398675832424633932090827150051" NO="1" P_CHI2="0.36086441553721804" P_Z="0.15997674309448545" STUDIES="2" TAU2="0.0" TOTAL_1="161" TOTAL_2="101" WEIGHT="99.99999999999999" Z="1.4051497831428186"><NAME>Up to 2 hours</NAME><DICH_DATA CI_END="1.0542703386464898" CI_START="0.6506310512359433" EFFECT_SIZE="0.8282155629547416" ESTIMABLE="YES" EVENTS_1="73" EVENTS_2="53" LOG_CI_END="0.022951988038087227" LOG_CI_START="-0.18666521394284058" LOG_EFFECT_SIZE="-0.08185661295237669" MODIFIED="2022-09-26 12:20:41 +0000" MODIFIED_BY="89398675832424633932090827150051" ORDER="1" O_E="0.0" SE="0.12313018206548132" STUDY_ID="STD-NCT02447991" TOTAL_1="153" TOTAL_2="92" VAR="0.0" WEIGHT="97.52425602922325"><FOOTNOTE>Denominator is the number of attacks, not the number of participants. </FOOTNOTE></DICH_DATA><DICH_DATA CI_END="7.674562832319093" CI_START="0.3710512653578078" EFFECT_SIZE="1.6875" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.8850536460490437" LOG_CI_START="-0.4305660830429185" LOG_EFFECT_SIZE="0.22724378150306254" MODIFIED="2022-09-26 12:20:41 +0000" MODIFIED_BY="89398675832424633932090827150051" ORDER="2" O_E="0.0" SE="0.7728015412913085" STUDY_ID="STD-Neuhauser-2003" TOTAL_1="8" TOTAL_2="9" VAR="0.0" WEIGHT="2.475743970776739"><FOOTNOTE>Denominator is the number of attacks, not the number of participants. </FOOTNOTE></DICH_DATA></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="1.1242999180510997" CI_START="0.8988359702937739" DF="0" EFFECT_SIZE="1.0052667346245328" ESTIMABLE="YES" EVENTS_1="97" EVENTS_2="54" I2="0.0" ID="CMP-001.01.02" LOG_CI_END="0.050882179008816" LOG_CI_START="-0.04631955598197655" LOG_EFFECT_SIZE="0.002281311513419728" MODIFIED="2022-09-26 12:20:41 +0000" MODIFIED_BY="89398675832424633932090827150051" NO="2" P_CHI2="1.0" P_Z="0.926697899101762" STUDIES="1" TAU2="0.0" TOTAL_1="109" TOTAL_2="61" WEIGHT="100.0" Z="0.09200017683311461"><NAME>&gt; 12 hours</NAME><DICH_DATA CI_END="1.1242999180510997" CI_START="0.8988359702937739" EFFECT_SIZE="1.0052667346245328" ESTIMABLE="YES" EVENTS_1="97" EVENTS_2="54" LOG_CI_END="0.050882179008816" LOG_CI_START="-0.04631955598197655" LOG_EFFECT_SIZE="0.002281311513419728" MODIFIED="2022-09-26 12:20:41 +0000" MODIFIED_BY="89398675832424633932090827150051" ORDER="3" O_E="0.0" SE="0.057096780289939766" STUDY_ID="STD-NCT02447991" TOTAL_1="109" TOTAL_2="61" VAR="0.0" WEIGHT="100.0"><FOOTNOTE>Analysis only includes people who did not take additional medication. </FOOTNOTE></DICH_DATA></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.02" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" METHOD="MH" MODIFIED="2022-11-25 11:42:03 +0000" MODIFIED_BY="5B1A013182E26AA200AF683A366CF7F3" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0"><NAME>Improvement in headache</NAME><GROUP_LABEL_1>Triptans</GROUP_LABEL_1><GROUP_LABEL_2>Placebo</GROUP_LABEL_2><GRAPH_LABEL_1>Favours placebo</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours triptans</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="0.09323979193188842" CI_END="0.9638782335200055" CI_START="0.4875017272757988" DF="1" EFFECT_SIZE="0.6854869099585698" ESTIMABLE="YES" EVENTS_1="45" EVENTS_2="40" I2="0.0" ID="CMP-001.02.01" LOG_CI_END="-0.01597782693795602" LOG_CI_START="-0.31202384120643056" LOG_EFFECT_SIZE="-0.16400083407219335" MODIFIED="2022-09-26 12:20:41 +0000" MODIFIED_BY="89398675832424633932090827150051" NO="1" P_CHI2="0.7600981590384395" P_Z="0.029891474959441392" STUDIES="2" TAU2="0.0" TOTAL_1="154" TOTAL_2="94" WEIGHT="100.00000000000001" Z="2.1715254570158042"><NAME>Up to 2 hours</NAME><DICH_DATA CI_END="0.9771775078683523" CI_START="0.4895219544446986" EFFECT_SIZE="0.6916283998587072" ESTIMABLE="YES" EVENTS_1="44" EVENTS_2="38" LOG_CI_END="-0.010026537933843999" LOG_CI_START="-0.310227825862124" LOG_EFFECT_SIZE="-0.16012718189798397" MODIFIED="2022-09-26 12:20:41 +0000" MODIFIED_BY="89398675832424633932090827150051" ORDER="4" O_E="0.0" SE="0.17633972254941316" STUDY_ID="STD-NCT02447991" TOTAL_1="149" TOTAL_2="89" VAR="0.0" WEIGHT="97.25083405314926"><FOOTNOTE>Denominator is the number of attacks, not the number of participants. </FOOTNOTE></DICH_DATA><DICH_DATA CI_END="3.9058693701782055" CI_START="0.06400623684672631" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.5917177144358473" LOG_CI_START="-1.19377770576381" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2022-09-26 12:20:41 +0000" MODIFIED_BY="89398675832424633932090827150051" ORDER="5" O_E="0.0" SE="1.0488088481701516" STUDY_ID="STD-Neuhauser-2003" TOTAL_1="5" TOTAL_2="5" VAR="0.0" WEIGHT="2.7491659468507503"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="1.3706535992827928" CI_START="0.9856953688594401" DF="0" EFFECT_SIZE="1.162345432788193" ESTIMABLE="YES" EVENTS_1="94" EVENTS_2="46" I2="0.0" ID="CMP-001.02.02" LOG_CI_END="0.13692771085917058" LOG_CI_START="-0.006257283907660963" LOG_EFFECT_SIZE="0.06533521347575481" MODIFIED="2022-09-26 12:20:41 +0000" MODIFIED_BY="89398675832424633932090827150051" NO="2" P_CHI2="1.0" P_Z="0.0736695233879262" STUDIES="1" TAU2="0.0" TOTAL_1="109" TOTAL_2="62" WEIGHT="100.0" Z="1.788660404580034"><NAME>&gt; 12 hours</NAME><DICH_DATA CI_END="1.3706535992827928" CI_START="0.9856953688594401" EFFECT_SIZE="1.162345432788193" ESTIMABLE="YES" EVENTS_1="94" EVENTS_2="46" LOG_CI_END="0.13692771085917058" LOG_CI_START="-0.006257283907660963" LOG_EFFECT_SIZE="0.06533521347575481" MODIFIED="2022-09-26 12:20:41 +0000" MODIFIED_BY="89398675832424633932090827150051" ORDER="6" O_E="0.0" SE="0.08410757470319195" STUDY_ID="STD-NCT02447991" TOTAL_1="109" TOTAL_2="62" VAR="0.0" WEIGHT="100.0"><FOOTNOTE>Analysis only includes people who did not take additional medication. </FOOTNOTE></DICH_DATA></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.03" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" METHOD="MH" MODIFIED="2023-03-21 17:49:08 +0000" MODIFIED_BY="8773" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0"><NAME>Improvement in other migrainous symptoms</NAME><GROUP_LABEL_1>Triptans</GROUP_LABEL_1><GROUP_LABEL_2>Placebo</GROUP_LABEL_2><GRAPH_LABEL_1>Favours placebo</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours triptans</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="0.0" CI_END="1.026740963943713" CI_START="0.6156674630146524" DF="0" EFFECT_SIZE="0.7950666666666667" ESTIMABLE="YES" EVENTS_1="67" EVENTS_2="50" I2="0.0" ID="CMP-001.03.01" LOG_CI_END="0.011460889439834766" LOG_CI_START="-0.2106537975317564" LOG_EFFECT_SIZE="-0.0995964540459608" MODIFIED="2022-09-26 12:20:41 +0000" MODIFIED_BY="89398675832424633932090827150051" NO="1" P_CHI2="1.0" P_Z="0.07879861342894674" STUDIES="1" TAU2="0.0" TOTAL_1="150" TOTAL_2="89" WEIGHT="100.0" Z="1.7576997323274606"><NAME>Nausea and vomiting at up to 2 hours</NAME><DICH_DATA CI_END="1.026740963943713" CI_START="0.6156674630146524" EFFECT_SIZE="0.7950666666666667" ESTIMABLE="YES" EVENTS_1="67" EVENTS_2="50" LOG_CI_END="0.011460889439834766" LOG_CI_START="-0.2106537975317564" LOG_EFFECT_SIZE="-0.0995964540459608" MODIFIED="2022-09-26 12:20:41 +0000" MODIFIED_BY="89398675832424633932090827150051" ORDER="7" O_E="0.0" SE="0.13047126661254543" STUDY_ID="STD-NCT02447991" TOTAL_1="150" TOTAL_2="89" VAR="0.0" WEIGHT="100.0"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="1.1117722734610764" CI_START="0.9307071820930997" DF="0" EFFECT_SIZE="1.0172189733593242" ESTIMABLE="YES" EVENTS_1="101" EVENTS_2="57" I2="0.0" ID="CMP-001.03.02" LOG_CI_END="0.046015838947902704" LOG_CI_START="-0.031186934704992064" LOG_EFFECT_SIZE="0.007414452121455336" MODIFIED="2022-09-26 12:20:41 +0000" MODIFIED_BY="89398675832424633932090827150051" NO="2" P_CHI2="1.0" P_Z="0.7065714621204591" STUDIES="1" TAU2="0.0" TOTAL_1="108" TOTAL_2="62" WEIGHT="100.0" Z="0.37646468994716403"><NAME>Nausea and vomiting at &gt; 12 to 72 hours</NAME><DICH_DATA CI_END="1.1117722734610764" CI_START="0.9307071820930997" EFFECT_SIZE="1.0172189733593242" ESTIMABLE="YES" EVENTS_1="101" EVENTS_2="57" LOG_CI_END="0.046015838947902704" LOG_CI_START="-0.031186934704992064" LOG_EFFECT_SIZE="0.007414452121455336" MODIFIED="2022-09-26 12:20:41 +0000" MODIFIED_BY="89398675832424633932090827150051" ORDER="8" O_E="0.0" SE="0.04534929140360337" STUDY_ID="STD-NCT02447991" TOTAL_1="108" TOTAL_2="62" VAR="0.0" WEIGHT="100.0"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="1.474640583863291" CI_START="0.7530365919852954" DF="0" EFFECT_SIZE="1.0537828617298817" ESTIMABLE="YES" EVENTS_1="59" EVENTS_2="33" I2="0.0" ID="CMP-001.03.03" LOG_CI_END="0.1686861820323883" LOG_CI_START="-0.12318391980038815" LOG_EFFECT_SIZE="0.02275113111600009" MODIFIED="2022-09-26 12:20:41 +0000" MODIFIED_BY="89398675832424633932090827150051" NO="3" P_CHI2="1.0" P_Z="0.759942375868492" STUDIES="1" TAU2="0.0" TOTAL_1="151" TOTAL_2="89" WEIGHT="100.0" Z="0.30555646032190625"><NAME>Photo- and phonophobia at up to 2 hours</NAME><DICH_DATA CI_END="1.474640583863291" CI_START="0.7530365919852954" EFFECT_SIZE="1.0537828617298817" ESTIMABLE="YES" EVENTS_1="59" EVENTS_2="33" LOG_CI_END="0.1686861820323883" LOG_CI_START="-0.12318391980038815" LOG_EFFECT_SIZE="0.02275113111600009" MODIFIED="2022-09-26 12:20:41 +0000" MODIFIED_BY="89398675832424633932090827150051" ORDER="9" O_E="0.0" SE="0.1714459425968781" STUDY_ID="STD-NCT02447991" TOTAL_1="151" TOTAL_2="89" VAR="0.0" WEIGHT="100.0"/></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="1.4220755349425065" CI_START="1.0139811958960012" DF="0" EFFECT_SIZE="1.2008154943934761" ESTIMABLE="YES" EVENTS_1="95" EVENTS_2="45" I2="0.0" ID="CMP-001.03.04" LOG_CI_END="0.15292266498551035" LOG_CI_START="0.0060299011567583275" LOG_EFFECT_SIZE="0.07947628307113436" MODIFIED="2022-09-26 12:20:41 +0000" MODIFIED_BY="89398675832424633932090827150051" NO="4" P_CHI2="1.0" P_Z="0.03393225745856955" STUDIES="1" TAU2="0.0" TOTAL_1="109" TOTAL_2="62" WEIGHT="100.0" Z="2.120875778825042"><NAME>Photo- and phonophobia at &gt; 12 to 72 hours</NAME><DICH_DATA CI_END="1.4220755349425065" CI_START="1.0139811958960012" EFFECT_SIZE="1.2008154943934761" ESTIMABLE="YES" EVENTS_1="95" EVENTS_2="45" LOG_CI_END="0.15292266498551035" LOG_CI_START="0.0060299011567583275" LOG_EFFECT_SIZE="0.07947628307113436" MODIFIED="2022-09-26 12:20:41 +0000" MODIFIED_BY="89398675832424633932090827150051" ORDER="10" O_E="0.0" SE="0.08628553660391693" STUDY_ID="STD-NCT02447991" TOTAL_1="109" TOTAL_2="62" VAR="0.0" WEIGHT="100.0"/></DICH_SUBGROUP></DICH_OUTCOME><DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.04" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" METHOD="MH" MODIFIED="2022-06-24 09:28:32 +0000" MODIFIED_BY="z2001201455262583895685719757999" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="5.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0"><NAME>Other adverse effects</NAME><GROUP_LABEL_1>Triptans</GROUP_LABEL_1><GROUP_LABEL_2>Placebo</GROUP_LABEL_2><GRAPH_LABEL_1>Favours triptans</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2><DICH_SUBGROUP CHI2="0.0" CI_END="2.562278693528386" CI_START="0.5952611649358444" DF="0" EFFECT_SIZE="1.235" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="8" I2="0.0" ID="CMP-001.04.01" LOG_CI_END="0.408626365252118" LOG_CI_START="-0.22529245006074883" LOG_EFFECT_SIZE="0.09166695759568456" MODIFIED="2022-09-26 12:20:41 +0000" MODIFIED_BY="89398675832424633932090827150051" NO="1" P_CHI2="1.0" P_Z="0.5708257564780054" STUDIES="1" TAU2="0.0" TOTAL_1="75" TOTAL_2="39" WEIGHT="100.0" Z="0.5668357875486945"><NAME>Gastrointestinal disturbance</NAME><DICH_DATA CI_END="2.562278693528386" CI_START="0.5952611649358444" EFFECT_SIZE="1.235" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="8" LOG_CI_END="0.408626365252118" LOG_CI_START="-0.22529245006074883" LOG_EFFECT_SIZE="0.09166695759568456" MODIFIED="2022-09-26 12:20:41 +0000" MODIFIED_BY="89398675832424633932090827150051" ORDER="11" O_E="0.0" SE="0.37236705006352194" STUDY_ID="STD-NCT02447991" TOTAL_1="75" TOTAL_2="39" VAR="0.0" WEIGHT="100.0"><FOOTNOTE>Upset stomach, nausea or vomiting</FOOTNOTE></DICH_DATA></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="4.072447451302921" CI_START="1.4272701401631296" DF="0" EFFECT_SIZE="2.410909090909091" ESTIMABLE="YES" EVENTS_1="51" EVENTS_2="11" I2="0.0" ID="CMP-001.04.02" LOG_CI_END="0.6098554891115695" LOG_CI_START="0.15450618003745153" LOG_EFFECT_SIZE="0.3821808345745105" MODIFIED="2022-09-26 12:20:41 +0000" MODIFIED_BY="89398675832424633932090827150051" NO="2" P_CHI2="1.0" P_Z="0.001001700909404826" STUDIES="1" TAU2="0.0" TOTAL_1="75" TOTAL_2="39" WEIGHT="100.0" Z="3.290048568957311"><NAME>Sleep disturbance</NAME><DICH_DATA CI_END="4.072447451302921" CI_START="1.4272701401631296" EFFECT_SIZE="2.410909090909091" ESTIMABLE="YES" EVENTS_1="51" EVENTS_2="11" LOG_CI_END="0.6098554891115695" LOG_CI_START="0.15450618003745153" LOG_EFFECT_SIZE="0.3821808345745105" MODIFIED="2022-09-26 12:20:41 +0000" MODIFIED_BY="89398675832424633932090827150051" ORDER="12" O_E="0.0" SE="0.26747443816556904" STUDY_ID="STD-NCT02447991" TOTAL_1="75" TOTAL_2="39" VAR="0.0" WEIGHT="100.0"><FOOTNOTE>Sleepiness or drowsiness</FOOTNOTE></DICH_DATA></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="3.4382509107053276" CI_START="0.21845732921133063" DF="0" EFFECT_SIZE="0.8666666666666667" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" I2="0.0" ID="CMP-001.04.03" LOG_CI_END="0.5363375666961754" LOG_CI_START="-0.6606333801938643" LOG_EFFECT_SIZE="-0.06214790674884446" MODIFIED="2022-09-26 12:20:41 +0000" MODIFIED_BY="89398675832424633932090827150051" NO="3" P_CHI2="1.0" P_Z="0.8387235283952613" STUDIES="1" TAU2="0.0" TOTAL_1="75" TOTAL_2="39" WEIGHT="100.0" Z="0.20352650874069853"><NAME>Cardiovascular side effects</NAME><DICH_DATA CI_END="3.4382509107053276" CI_START="0.21845732921133063" EFFECT_SIZE="0.8666666666666667" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" LOG_CI_END="0.5363375666961754" LOG_CI_START="-0.6606333801938643" LOG_EFFECT_SIZE="-0.06214790674884446" MODIFIED="2022-09-26 12:20:41 +0000" MODIFIED_BY="89398675832424633932090827150051" ORDER="13" O_E="0.0" SE="0.7031066593049552" STUDY_ID="STD-NCT02447991" TOTAL_1="75" TOTAL_2="39" VAR="0.0" WEIGHT="100.0"><FOOTNOTE>Heart rhythm problems or chest pain</FOOTNOTE></DICH_DATA></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="2.1446727479199708" CI_START="0.2471164892238266" DF="0" EFFECT_SIZE="0.728" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" I2="0.0" ID="CMP-001.04.04" LOG_CI_END="0.33136103329686767" LOG_CI_START="-0.6070982746707932" LOG_EFFECT_SIZE="-0.13786862068696282" MODIFIED="2022-09-26 12:20:41 +0000" MODIFIED_BY="89398675832424633932090827150051" NO="4" P_CHI2="1.0" P_Z="0.5646998156170577" STUDIES="1" TAU2="0.0" TOTAL_1="75" TOTAL_2="39" WEIGHT="100.0" Z="0.5758747957433497"><NAME>Paraesthesia, flushing, warm or hot sensations</NAME><DICH_DATA CI_END="2.1446727479199708" CI_START="0.2471164892238266" EFFECT_SIZE="0.728" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.33136103329686767" LOG_CI_START="-0.6070982746707932" LOG_EFFECT_SIZE="-0.13786862068696282" MODIFIED="2022-09-26 12:20:41 +0000" MODIFIED_BY="89398675832424633932090827150051" ORDER="14" O_E="0.0" SE="0.5512556429486993" STUDY_ID="STD-NCT02447991" TOTAL_1="75" TOTAL_2="39" VAR="0.0" WEIGHT="100.0"><FOOTNOTE>Weakness of arms, legs or face or loss of sensation</FOOTNOTE></DICH_DATA></DICH_SUBGROUP><DICH_SUBGROUP CHI2="0.0" CI_END="1.6008047050587366" CI_START="0.3524276880569685" DF="0" EFFECT_SIZE="0.7511111111111111" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="9" I2="0.0" ID="CMP-001.04.05" LOG_CI_END="0.2043383521011956" LOG_CI_START="-0.4529299790965735" LOG_EFFECT_SIZE="-0.12429581349768898" MODIFIED="2022-09-26 12:20:41 +0000" MODIFIED_BY="89398675832424633932090827150051" NO="5" P_CHI2="1.0" P_Z="0.45851376087608064" STUDIES="1" TAU2="0.0" TOTAL_1="75" TOTAL_2="39" WEIGHT="100.0" Z="0.7412963817703706"><NAME>Headache</NAME><DICH_DATA CI_END="1.6008047050587366" CI_START="0.3524276880569685" EFFECT_SIZE="0.7511111111111111" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="9" LOG_CI_END="0.2043383521011956" LOG_CI_START="-0.4529299790965735" LOG_EFFECT_SIZE="-0.12429581349768898" MODIFIED="2022-09-26 12:20:41 +0000" MODIFIED_BY="89398675832424633932090827150051" ORDER="15" O_E="0.0" SE="0.38608267127628126" STUDY_ID="STD-NCT02447991" TOTAL_1="75" TOTAL_2="39" VAR="0.0" WEIGHT="100.0"><FOOTNOTE>Worsening of headache</FOOTNOTE></DICH_DATA></DICH_SUBGROUP></DICH_OUTCOME></COMPARISON></ANALYSES_AND_DATA><FIGURES/><FEEDBACK/><APPENDICES/><EXTENSIONS/></COCHRANE_REVIEW>